INTUITIVE SURGICAL INC (ISRG)

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive care. The company, founded over 30 years ago, describes its mission as expanding physicians' ability to heal without constraints. It offers an ecosystem of robotic-assisted systems, instruments and accessories, customer learning, and customer support services, all connected by a digital portfolio that provides insights across the care continuum. It uses the Quintuple Aim (better outcomes, better patient experiences, better care team experiences, lower total cost of care per patient episode, and broader access to care) as its guiding framework.

Its platforms are the da Vinci surgical systems and the Ion endoluminal system. Da Vinci was first launched in 1999 and is cleared for procedures across general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties, among others. Current models include the fifth-generation da Vinci 5, the fourth-generation da Vinci X, Xi and SP (single-port), and the third-generation da Vinci Si. Each system combines a surgeon console, a patient-side cart with robotic arms, and a 3DHD vision system, with features such as Firefly fluorescence imaging and Integrated Table Motion. Ion, FDA-cleared in 2019, is a flexible, catheter-based robotic platform whose first cleared indication is minimally invasive lung biopsy. Instruments and accessories include wristed da Vinci instruments, SureForm and EndoWrist staplers and reloads, energy instruments (Vessel Sealer Extend, SynchroSeal) with E-100 and E-200 generators, sterile drapes, endoscopes and camera heads, and Ion catheters, vision probes and Flexision biopsy needles. The company also provides training pathways and learning technologies (Intuitive Learning, SimNow, Telepresence, Case Insights), service and support (installation, repair, maintenance, 24/7 technical support, OnSite monitoring, software updates), perioperative consulting, Custom Hospital Analytics, Intuitive 3D Models, and the My Intuitive and My Intuitive+ digital offerings.

Customers are hospitals and healthcare systems, along with the surgeons, physicians, and care teams who use the products. Payers are also a stakeholder in the company's value proposition. Intuitive sells in the U.S. and in other countries, where it has obtained clearances for many indications. Adoption occurs by procedure and by geographic market and is driven by the relative patient value and total intervention costs of da Vinci and Ion procedures compared with alternatives.

Intuitive supports customers through a network of field service engineers across the U.S., Canada, Europe, and Asia and relationships with distributors around the globe. It runs training centers, and its systems are connected to a network that allows remote monitoring and software updates. Integrated Table Motion works with an operating table sold by Hillrom, now part of Baxter International. The text does not describe suppliers, manufacturing facilities, competitors, or headquarters.